Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
108.35
-6.31 (-5.50%)
At close: Jul 31, 2026, 4:00 PM EDT
108.25
-0.10 (-0.09%)
After-hours: Jul 31, 2026, 7:42 PM EDT
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $725.81 million as of July 31, 2026. Its market cap has increased by 178.22% in one year.
Market Cap
725.81M
Enterprise Value
588.55M
1-Year Change
178.22%
Ranking
Category
Stock Price
$108.35
ChartMarket Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $725.81M, an increase of 162.83%. That is a compound annual growth rate of 15.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 725.81M | 66.33% |
| Dec 31, 2025 | 436.37M | 225.25% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 760.73M |
| SpyGlass Pharma | 753.25M |
| Candel Therapeutics | 733.44M |
| Bright Minds Biosciences | 731.41M |
| Aclaris Therapeutics | 726.25M |
| Pharming Group | 712.11M |
| Faeth Therapeutics | 702.21M |
| Tenax Therapeutics | 699.96M |